Ultrasound doesn’t lead to better outcomes in T2T strategies: BIODAM


There is growing evidence that ultrasound remission may not be a helpful measure in establishing treat-to-target strategies in rheumatoid arthritis, EULAR delegates were told. Dr Alexandre Sepriano from the Leiden University Medical Centre presented two year findings from the observational BIODAM study involving a subset of 130 patients with rheumatoid arthritis (RA) treated under a ...


Already a member? Login to keep reading


OR
© 2017 the limbic